Carter Bankshares Details $98M Gain from Major Loan Sale, Boosting Q1 EPS by $3.50
CARE sits 72% above its 52-week low of $15.035.
Summary
Carter Bankshares, Inc. disclosed the detailed financial impact of resolving its largest nonperforming loan, reporting a $98.0 million gain and a $3.50 diluted EPS boost for Q1 2026, significantly improving asset quality and earnings.
Key Events · M&A and Partnerships · CARE
-
Quantified Impact of Major Loan Sale
The company reported a total gain, recovery, and reserve release of $98.0 million from the successful resolution of its largest legacy nonperforming credit relationship on March 26, 2026.
-
Significant Q1 EPS Boost
The transaction contributed $77.4 million to net income after tax, resulting in a $3.50 diluted earnings per share impact for the first quarter of 2026.
-
Improved Asset Quality
The resolution of the nonperforming loan significantly reduced the Nonperforming Loans (NPLs) to Total Portfolio Loans ratio to 0.64% and improved other asset quality metrics.
-
Strong Overall Q1 2026 Financials
The company reported a GAAP Q1 2026 diluted EPS of $3.88, a Return on Average Assets (ROA) of 7.13%, and a Return on Average Shareholders' Equity (ROE) of 80.05%, with these figures significantly boosted by the transaction.
Analysis · CARE · Finance
This 8-K filing, through its investor presentation, provides critical financial details regarding the previously announced resolution of Carter Bankshares' largest nonperforming credit relationship. The quantified $98.0 million gain, recovery, and reserve release from this transaction, which translates to a $3.50 diluted EPS impact, represents a substantial positive development. This event significantly de-risks the balance sheet, improves asset quality, and dramatically boosts Q1 2026 earnings, reinforcing the company's strong financial performance as it trades near its 52-week high. This detailed quantification is new and highly material information for investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CARE was trading at $25.88 on NASDAQ in the Finance sector, with a market capitalization of approximately $573.5M. The 52-week trading range was $15.04 to $26.13. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.